Literature DB >> 29061505

Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180.

Kazuhiro Koikawa1, Kenoki Ohuchida2, Shin Takesue1, Yohei Ando1, Shin Kibe1, Hiromichi Nakayama1, Sho Endo1, Toshiya Abe1, Takashi Okumura1, Kohei Horioka1, Masafumi Sada1, Chika Iwamoto3, Taiki Moriyama1, Kohei Nakata1, Yoshihiro Miyasaka1, Riichi Ohuchida4, Tatsuya Manabe1, Takao Ohtsuka1, Eishi Nagai1, Kazuhiro Mizumoto1, Makoto Hashizume3, Masafumi Nakamura2.   

Abstract

Specific cell populations leading the local invasion of cancer are called "leading cells". However, the underlying mechanisms are unclear. Here, we identified leading cells in pancreatic cancer and determined how these cells lead and promote cancer cell invasion in the extracellular matrix (ECM). Using three-dimensional matrix remodeling assay, we found that pancreatic stellate cells (PSCs) frequently invaded the collagen matrix with pancreatic cancer cells (PCCs), which invaded behind the invading PSCs. In addition, invading PSCs changed the alignment of collagen fibers, resulting in ECM remodeling and an increase in the parallel fibers along the direction of invading PSCs. Endo180 expression was higher in PSCs than in PCCs, Endo180 knockdown in PSCs attenuated the invasive abilities of PSCs and co-cultured PCCs, and decreased the expression level of phosphorylated myosin light chain 2 (MLC2). In mouse models, Endo180-knockdown PSCs suppressed tumor growth and changes in collagen fiber orientation in co-transplantation with PCCs. Our findings suggest that PSCs lead the local invasion of PCCs by physically remodeling the ECM, possibly via the function of Endo180, which reconstructs the actin cell skeleton by phosphorylation of MLC2.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endo180; Extracellular matrix remodeling; Leading cells; Pancreatic cancer; Pancreatic stellate cells

Mesh:

Substances:

Year:  2017        PMID: 29061505     DOI: 10.1016/j.canlet.2017.10.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

Review 1.  Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting.

Authors:  Nardeen Perko; Shaker A Mousa
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

2.  Conditioned media of pancreatic cancer cells and pancreatic stellate cells induce myeloid-derived suppressor cells differentiation and lymphocytes suppression.

Authors:  Yuen Ping Chong; Evelyn Priya Peter; Feon Jia Ming Lee; Chu Mun Chan; Shereen Chai; Lorni Poh Chou Ling; Eng Lai Tan; Sook Han Ng; Atsushi Masamune; Siti Aisyah Abd Ghafar; Norsharina Ismail; Ket Li Ho
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

3.  Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.

Authors:  Kazuhiro Koikawa; Shin Kibe; Futoshi Suizu; Nobufumi Sekino; Nami Kim; Theresa D Manz; Benika J Pinch; Dipikaa Akshinthala; Ana Verma; Giorgio Gaglia; Yutaka Nezu; Shizhong Ke; Chenxi Qiu; Kenoki Ohuchida; Yoshinao Oda; Tae Ho Lee; Babara Wegiel; John G Clohessy; Nir London; Sandro Santagata; Gerburg M Wulf; Manuel Hidalgo; Senthil K Muthuswamy; Masafumi Nakamura; Nathanael S Gray; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Cell       Date:  2021-08-12       Impact factor: 66.850

Review 4.  Polymer nanoparticle-assisted chemotherapy of pancreatic cancer.

Authors:  Tianqi Su; Bo Yang; Tianren Gao; Tongjun Liu; Jiannan Li
Journal:  Ther Adv Med Oncol       Date:  2020-05-08       Impact factor: 8.168

Review 5.  The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.

Authors:  Qiqing Sun; Bo Zhang; Qiangsheng Hu; Yi Qin; Wenyan Xu; Wensheng Liu; Xianjun Yu; Jin Xu
Journal:  Theranostics       Date:  2018-10-06       Impact factor: 11.556

6.  Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.

Authors:  Hyun Ju Hwang; Min-Suk Oh; Dong Woo Lee; Hyo-Jeong Kuh
Journal:  J Exp Clin Cancer Res       Date:  2019-06-14

7.  Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells.

Authors:  Omidreza Firuzi; Pei Pei Che; Btissame El Hassouni; Mark Buijs; Stefano Coppola; Matthias Löhr; Niccola Funel; Rainer Heuchel; Ilaria Carnevale; Thomas Schmidt; Giulia Mantini; Amir Avan; Luciano Saso; Godefridus J Peters; Elisa Giovannetti
Journal:  Cancers (Basel)       Date:  2019-05-08       Impact factor: 6.639

8.  Pancreatic Stellate Cells Serve as a Brake Mechanism on Pancreatic Acinar Cell Calcium Signaling Modulated by Methionine Sulfoxide Reductase Expression.

Authors:  Jin Shuai Liu; Zong Jie Cui
Journal:  Cells       Date:  2019-02-01       Impact factor: 6.600

9.  Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis.

Authors:  Ute Jungwirth; Antoinette van Weverwijk; Rachel J Evans; Liam Jenkins; David Vicente; John Alexander; Qiong Gao; Syed Haider; Marjan Iravani; Clare M Isacke
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

10.  Overexpression of Gremlin 1 by sonic hedgehog signaling promotes pancreatic cancer progression.

Authors:  Yongtian Yu; Liang Cheng; Bin Yan; Cancan Zhou; Weikun Qian; Ying Xiao; Tao Qin; Junyu Cao; Liang Han; Qingyong Ma; Jiguang Ma
Journal:  Int J Oncol       Date:  2018-09-26       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.